Source: PR Newswire

GSK: Contact Levi & Korsinsky by April 7, 2025 Deadline to Join Class Action Against GSK plc(GSK)

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in GSK plc ("GSK" or the "Company") (NYSE: GSK) of a class action securities lawsuit. CLASS...

Read full article »

GSK's Competitors | GSK's News | GSK's Financials

Followers on Owler

29,116

Annual Revenue

$10-50B

Employees

50-100K

CEO

Dame Emma Walmsley

CEO Approval Rating

67/100

GSK is an England-based multinational biopharmaceutical company that develops and markets medicinal drugs and vaccines for the treatment of a variety of diseases.